- Diagnostic Différentiel
Drug Information for INCRELEX™ (mecasermin [rDNA origin] injection) (Tercica, Inc.): CONTRAINDICATIONS
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- STABILITY AND STORAGE
- HOW SUPPLIED
- Liens externes liés à INCRELEX™ (mecasermin [rDNA origin] injection) (Tercica, Inc.)
INCRELEX™ should not be used for growth promotion in patients with closed epiphyses.
INCRELEX™ is contraindicated in the presence of active or suspected neoplasia, and therapy should be discontinued if evidence of neoplasia develops.
Intravenous administration of INCRELEX™ is contraindicated.
INCRELEX™ should not be used by patients who are allergic to mecasermin (IGF-1) or any of the inactive ingredients in INCRELEX™.
- Drug Information Provided by National Library of Medicine (NLM).